Controversial Dwarfism Drug Helps Regulate Bone Development In Children

Researchers at BioMarin Pharmaceutical have created a controversial drug that helps regulate bone development in children with the most common type of dwarfism. But some argue it's a profit-driven solution in search of a problem.

Host Tonya Mosley talks with reporter Damian Garde (@damiangarde), who has been covering the story for our partners at STAT, the health and medicine publication.